At Apheris, we power federated data networks in life sciences to address the data bottleneck in training highly performant ML models. Publicly available, molecular datasets are insufficient to train high-quality ML models that meet industry requirements. We address this by hosting networks where pharma organizations collaboratively train higher quality models on their combined data.
The Apheris product is a set of drug discovery applications enriched with the proprietary data of network participants. Our federated computing infrastructure with built-in governance and privacy controls ensures that the data IP and ownership always stay with the data custodians.
We currently host two flagship networks: the
AISB Network, focused on protein co-folding and binding affinity prediction, and the
ADMET Network, focused on small-molecule property prediction. In addition, we have just launched our
Co-Folding Application, which enables pharma teams to deploy models like OpenFold3 and Boltz-2 directly in their own environments - with more capabilities to follow.